Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Learn what's the best investment strategy to help you maximize your returns and achieve your financial goals.
22,631 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Vertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
A director bought a sizable stake in VIA Transportation, prompting questions about the stock’s future. This guide bre...
Choosing between two healthcare giants comes down to balance: steady income or longer-term growth. This guide dives i...
CoreWeave delivers a record bookings quarter but sinks on concentration fears, while QQQ holds steady amid AI volatil...
In the first half of 2026, american superconductor corporation rallied as grid modernization and superconducting tech...
Soleno's Q4 2025 earnings paint a picture of growth with new products and expanding margins. This guide breaks down t...
February brought a sharp pullback for Robinhood, driven by crypto swings and a broader shift in its business model. T...
AI is reshaping business models across industries. Here are three AI stocks you can buy and hold for the long term, w...
In quarterly 13F disclosures, billionaire loeb sold shares of major AI players while adding to a smaller AI stock tha...
Lemonade stock surged about 16% this week thanks to a powerful mix of analyst optimism and progress in its AI-based u...
What looks like a bargain today could turn into a meaningful gain by 2026. This guide shows how patient investors ide...